Pfizer/BioNTech applied for emergency use authorization of their Omicron-adapted COVID-19 vaccine dose in the United States.
This post was created with our nice and easy submission form. Create your post!
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%Accept